Scinovex
article Open AccessTop 10% cited

Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains

Infection and Immunity · 1983 · Vol. 42(1) · pp. 170–177
Robert E. W. HancockLucy M. MuthariaL ChanR P DarveauDavid P. SpeertGerald B. Pier

Abstract

Twenty-six Pseudomonas aeruginosa strains from patients with cystic fibrosis were typed by the Fisher immunotyping scheme. Only 6 strains were agglutinated by a single typing serum, whereas 15 strains were agglutinated with more than one serum and 5 were not agglutinated by any serum. Neither the polyagglutinable nor the nonagglutinable strains were typable by hemagglutination inhibition or immunodiffusion, suggesting that these polyagglutinable strains did not express multiple serotype antigens, but were instead being agglutinated by antibody to nonserotype determinants. Four typable isolates were resistant to pooled normal human serum, whereas the 12 polyagglutinable and nonagglutinable isolates studied were very sensitive to normal human serum. The outer membranes of 16 strains were isolated and characterized. The data suggested, in general, strong conservation of outer membrane protein patterns. Lipopolysaccharides (LPS) were purified by a new technique which allowed isolation of both rough and smooth LPS in high yields. Three of four typable, serum-resistant strains examined had amounts of smooth, O-antigen-containing LPS equivalent to our laboratory wild type, P. aeruginosa PAO1 strain H103. In contrast, 10 of 12 polyagglutinable or nonagglutinable, serum-sensitive strains had very little or no smooth, O-antigen-containing LPS, and the other two contained less smooth LPS than our wild-type strain H103. In agreement with this data, five independent, rough, LPS O-antigen-deficient mutants of strain H103 were nontypable and serum sensitive. We suggest that the LPS defects described here represent a significant new property of many P. aeruginosa strains associated with cystic fibrosis.

Antibiotic Resistance in BacteriaCystic Fibrosis Research AdvancesBacteriophages and microbial interactionsBiologyMicrobiologyPseudomonas aeruginosaSerotypeAntigenBacterial outer membraneLipopolysaccharideAntiserumStrain (injury)Typing

MeSH terms

Bacterial Outer Membrane ProteinsBacterial ProteinsBlood Bactericidal ActivityCystic FibrosisHemagglutination TestsHumansLipopolysaccharidesMembrane ProteinsPseudomonas aeruginosaSerotyping
Citations
463
FWCI
5.93
field-weighted impact
References
32
Percentile
98%
vs. same field & year
Citations per year
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine · 2003 · 1,628 citations
Lung Infections Associated with Cystic Fibrosis
Clinical Microbiology Reviews · 2002 · 1,610 citations
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.